These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28683724)

  • 21. Severe Community-acquired Pneumonia Caused by Acinetobacter baumannii Successfully Treated with the Initial Administration of Meropenem Based on the Sputum Gram Staining Findings.
    Iwasawa Y; Hosokawa N; Harada M; Hayano S; Shimizu A; Suzuki D; Nakashima K; Yaegashi M
    Intern Med; 2019 Jan; 58(2):301-305. PubMed ID: 30210104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China.
    Yang J; Chen Y; Jia X; Luo Y; Song Q; Zhao W; Wang Y; Liu H; Zheng D; Xia Y; Yu R; Han X; Jiang G; Zhou Y; Zhou W; Hu X; Liang L; Han L
    Clin Microbiol Infect; 2012 Dec; 18(12):E506-13. PubMed ID: 23036089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols.
    Davis JS; McMillan M; Swaminathan A; Kelly JA; Piera KE; Baird RW; Currie BJ; Anstey NM
    Chest; 2014 Oct; 146(4):1038-1045. PubMed ID: 24901292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro.
    Lázaro-Díez M; Navascués-Lejarza T; Remuzgo-Martínez S; Navas J; Icardo JM; Acosta F; Martínez-Martínez L; Ramos-Vivas J
    Microbes Infect; 2016 Sep; 18(9):559-64. PubMed ID: 27235198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
    Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F
    Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.
    Wong D; Nielsen TB; Bonomo RA; Pantapalangkoor P; Luna B; Spellberg B
    Clin Microbiol Rev; 2017 Jan; 30(1):409-447. PubMed ID: 27974412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.
    Rodríguez-Hernández MJ; Pachón J; Pichardo C; Cuberos L; Ibáñez-Martínez J; García-Curiel A; Caballero FJ; Moreno I; Jiménez-Mejías ME
    J Antimicrob Chemother; 2000 Apr; 45(4):493-501. PubMed ID: 10747827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
    Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
    BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome.
    Leung WS; Chu CM; Tsang KY; Lo FH; Lo KF; Ho PL
    Chest; 2006 Jan; 129(1):102-9. PubMed ID: 16424419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States.
    Wisplinghoff H; Paulus T; Lugenheim M; Stefanik D; Higgins PG; Edmond MB; Wenzel RP; Seifert H
    J Infect; 2012 Mar; 64(3):282-90. PubMed ID: 22209744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of fulminant community-acquired Acinetobacter pneumonia in a healthy woman].
    Morioka H; Matsumoto S; Kojima E; Takada K; Shizu M; Okachi S
    Nihon Kokyuki Gakkai Zasshi; 2011 Jan; 49(1):57-61. PubMed ID: 21384683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific.
    Ong CW; Lye DC; Khoo KL; Chua GS; Yeoh SF; Leo YS; Tambyah PA; Chua AC
    Respirology; 2009 Nov; 14(8):1200-5. PubMed ID: 19909464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of invasive Acinetobacter species isolates recovered in a pediatric academic center.
    Jain AL; Harding CM; Assani K; Shrestha CL; Haga M; Leber A; Munson RS; Kopp BT
    BMC Infect Dis; 2016 Jul; 16():346. PubMed ID: 27449800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem.
    Joly-Guillou ML; Wolff M; Pocidalo JJ; Walker F; Carbon C
    Antimicrob Agents Chemother; 1997 Feb; 41(2):345-51. PubMed ID: 9021190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia.
    Coron N; Pavlickova S; Godefroy A; Pailhoriès H; Kempf M; Cassisa V; Marsollier L; Marion E; Joly-Guillou ML; Eveillard M
    Future Microbiol; 2017 Jun; 12():707-719. PubMed ID: 28540732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between bacteremia caused by Acinetobacter pittii and Acinetobacter nosocomialis.
    Liu YM; Lee YT; Kuo SC; Chen TL; Liu CP; Liu CE
    J Microbiol Immunol Infect; 2017 Feb; 50(1):62-67. PubMed ID: 25735795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia.
    Kamata K; Suzuki H; Kanemoto K; Tokuda Y; Shiotani S; Hirose Y; Suzuki M; Ishikawa H
    J Infect Chemother; 2015 Aug; 21(8):596-603. PubMed ID: 26070781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The success of acinetobacter species; genetic, metabolic and virulence attributes.
    Peleg AY; de Breij A; Adams MD; Cerqueira GM; Mocali S; Galardini M; Nibbering PH; Earl AM; Ward DV; Paterson DL; Seifert H; Dijkshoorn L
    PLoS One; 2012; 7(10):e46984. PubMed ID: 23144699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.